RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,906 | -57.3% | 138,391 | +0.2% | 0.00% | – |
| Q2 2023 | $151,942 | -7.6% | 138,129 | 0.0% | 0.00% | – |
| Q1 2023 | $164,374 | -0.9% | 138,129 | +24.1% | 0.00% | – |
| Q4 2022 | $165,892 | -8.9% | 111,337 | -0.4% | 0.00% | – |
| Q3 2022 | $182,000 | +119.3% | 111,783 | +6.6% | 0.00% | – |
| Q2 2022 | $83,000 | -56.1% | 104,843 | 0.0% | 0.00% | – |
| Q1 2022 | $189,000 | +4.4% | 104,843 | -0.8% | 0.00% | – |
| Q4 2021 | $181,000 | -17.4% | 105,716 | -0.5% | 0.00% | – |
| Q3 2021 | $219,000 | -10.6% | 106,295 | +0.2% | 0.00% | – |
| Q2 2021 | $245,000 | -63.2% | 106,061 | -55.6% | 0.00% | – |
| Q1 2021 | $666,000 | -6.6% | 238,977 | -4.5% | 0.00% | – |
| Q4 2020 | $713,000 | +21.7% | 250,169 | -10.5% | 0.00% | – |
| Q3 2020 | $586,000 | -59.0% | 279,508 | -11.2% | 0.00% | – |
| Q2 2020 | $1,431,000 | -35.1% | 314,702 | +16.5% | 0.00% | -100.0% |
| Q1 2020 | $2,206,000 | -52.8% | 270,031 | +5.9% | 0.00% | 0.0% |
| Q4 2019 | $4,673,000 | +67.7% | 254,943 | +1.4% | 0.00% | 0.0% |
| Q3 2019 | $2,786,000 | +17.7% | 251,487 | +8.0% | 0.00% | 0.0% |
| Q2 2019 | $2,368,000 | +70.1% | 232,833 | -2.0% | 0.00% | – |
| Q1 2019 | $1,392,000 | -11.5% | 237,507 | +7.2% | 0.00% | – |
| Q4 2018 | $1,572,000 | +0.3% | 221,483 | +0.4% | 0.00% | – |
| Q3 2018 | $1,567,000 | +41.3% | 220,508 | -0.2% | 0.00% | – |
| Q2 2018 | $1,109,000 | -41.7% | 220,965 | +28.0% | 0.00% | – |
| Q1 2018 | $1,901,000 | +22.1% | 172,668 | +2.6% | 0.00% | – |
| Q4 2017 | $1,557,000 | +22.2% | 168,357 | +18.7% | 0.00% | – |
| Q3 2017 | $1,274,000 | +1.6% | 141,841 | -20.5% | 0.00% | – |
| Q2 2017 | $1,254,000 | +325.1% | 178,437 | +428.5% | 0.00% | – |
| Q1 2017 | $295,000 | +126.9% | 33,761 | +108.2% | 0.00% | – |
| Q4 2016 | $130,000 | +1.6% | 16,213 | +11.9% | 0.00% | – |
| Q3 2016 | $128,000 | – | 14,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |